Although TRPV4 inhibition represents a potential therapeutic option for IBS or inflammatory bowel disease (IBD) [27], directly blocking TRPV4 might negatively affect normal physiological function [15]. The gene discussed is TRPV4; the disease is inflammatory bowel disease.